RxDoctor Payments Data

Mallory Iverson

Nurse Practitioner · Wauconda, ILNPI 1366818692

Payments from drug & device makers

$8,109in general payments, 2019–2025

Across 433 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Bayer$503
  • AstraZeneca$447
  • Pfizer$426
  • Otsuka America Pharmaceutical, Inc.$421
  • Novo Nordisk$415
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$7,99899%
  • Education$1111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie114$1,440
Bayer20$503
AstraZeneca(2 entities)15$447
Pfizer20$426
Otsuka America Pharmaceutical, Inc.17$421
Novo Nordisk13$415
Lilly USA, LLC19$396
Corcept Therapeutics16$340
Philips North America LLC20$308
Teva Pharmaceuticals USA, Inc.9$247
Sobi, Inc14$230
Paratek Pharmaceuticals, Inc.13$210
GSK12$187
Amgen8$164
Agile Therapeutics, Inc.8$160
Neurocrine Biosciences, Inc.5$149
Lundbeck LLC9$149
Verona Pharma, Inc.9$149
Organon6$115
Ultragenyx Pharmaceutical Inc.6$108
Sanofi Pasteur Inc.6$106
Exact Sciences4$94
Cranial Technologies, Inc5$86
Biohaven Pharmaceuticals, Inc.4$86
Biohaven Pharmaceutical Holding Company Ltd.3$73
Xeris Pharmaceuticals, Inc.4$69
Axsome Therapeutics, Inc.3$66
Kyowa Kirin, Inc.3$65
Dexcom, Inc.2$57
Phadia US Inc.1$55
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$54
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$52
Daiichi Sankyo Inc.2$52
Agios Pharmaceuticals, Inc.2$51
Roche Diabetes Care, Inc.3$42
Boehringer Ingelheim2$41
Hologic Sales And Service, LLC2$36
Scynexis, Inc.2$36
Merck2$33
Amarin Pharma, Inc.2$32
Avanir Pharmaceuticals, Inc.1$30
Phathom Pharmaceuticals, Inc.2$30
Baxter Healthcare1$25
Cipher Pharmaceuticals US LLC1$24
Sunovion Pharmaceuticals Inc.2$24
Mannkind Corporation1$22
BD1$21
Astellas Pharma US Inc1$20
Kowa Pharmaceuticals America, Inc.1$19
Mylan Specialty L.p.1$19
Exeltis, USA Inc.1$16
ARS Pharmaceuticals Operations, Inc.1$16
USWM, LLC1$15
Viatris Specialty LLC1$14
Biomarin Pharmaceutical Inc.1$13
Global Blood Therapeutics, Inc.1$13
Redhill Biopharma Inc.1$13
Takeda Pharmaceuticals U.S.A., Inc.1$12
Aurinia Pharma U.S., Inc.1$12
Genentech USA, Inc.1$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,109 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$61,343
Medicare patients
182
Services billed
1,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide96$94,672
TrulicityDulaglutide39$36,087
JardianceEmpagliflozin19$27,116
EliquisApixaban29$23,036
FarxigaDapagliflozin Propanediol11$16,683
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$15,818
SymbicortBudesonide/Formoterol Fumarate12$3,641
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$3,394
Albuterol Sulfate HfaAlbuterol Sulfate51$3,035
Fenofibrate13$1,615
Rosuvastatin Calcium52$1,609
Atorvastatin Calcium104$877
Acetaminophen-CodeineAcetaminophen With Codeine45$823
Levothyroxine Sodium64$802
Amlodipine Besylate83$726

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$415$94,67296 claims
Lilly USA, LLCTrulicity$396$36,08739 claims
Boehringer IngelheimJardiance$41$27,11619 claims
PfizerEliquis$426$23,03629 claims
AstraZenecaFarxiga, Symbicort$447$20,32523 claims
GSKTrelegy Ellipta$187$15,81813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Wauconda

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →